Our Products
In September 2017, we received FDA approval for XHANCE® (fluticasone propionate). Please see Instructions for Use, Important Safety Information, and full Prescribing Information at www.XHANCE.com.
ONZETRA® Xsail® (sumatriptan nasal powder), licensed to Currax Pharmaceuticals LLC, has been approved for the delivery of low-dose sumatriptan using an Optinose Bi-Directional™ Exhalation Delivery System. See Instructions for Use, Important Safety Information, and full Prescribing Information at www.ONZETRAHCP.com.
Exhalation Delivery Systems
See how our products transform nasal treatment.
Partnership Opportunities
Optinose Exhalation Delivery Systems have unique capabilities that may be ideally suited to solving your specific delivery challenges, leveraging deep mucosal surface delivery for treatment of local, systemic, or central nervous system diseases.